E133 Losartan® improves diastolic function of hypertensive patients

A

1

J

1

N 9 4 PH

2

9

-

8

I P

L H J T I F B

A

D

N V

O

M

p R

t

t

v s

s b

S

J

r

a d

T b

h f av d

f u r 3m a t m f S a s

p y

Apv P w

w

a p i

t

e

s I

r o s

0

S B P S t

w k p (

l

T oa p i

a s wis l

c d

l p

s d

s

R u

R ( s 2 E f fe

( v

(

= I ~ 0 v 2 ~ 0 E T c s w =a p w i se h O T mw y s e dy o ep

pe s s

f

(

a t

f

t

l v = f Y

e t

p H R r

f I c c

p d 3m As o i

w

as t w al t p

e

p

w p a

t

a p c s

W

f A w e m b d n p gP m c s ho

p

cs f n

d

d

I

A

r

t k

T t

y a

a

e d

g

a

W r

oS c p at t

f n B

p i

r b f d t f C L C w n a h L d n r t e K

1

f

t a

1I

e

d

aa

g a

d i

o I V e i ?w h C I dt i an o St w A i ( c c W y r thy a 4 a p p o u unt sc f th iwit = t t w o el e i e l 1 i n d tio ~ naf toy y e a ( aC ( m L & t e i c B S s 2 e c a p s e w o ay s p B p h r s w w c t y P e e r d i l m s d r eBc u i ml wt r i W @ i W D S w m s a l Vm. i . C . g F . w I i( 6 r i 1 0 cv v a5 o 1 ne y iP 5i v l a e y ) tg t ,m t tp. A aog if p ow 7 y ao ( 1 m s s f , p n w ll e ll e Tt a

G t (

r

v w w

T W E A J fN PATENTS Y WJTH C CHANNEL BL4XXCERS ESSENTIAL HYPERTENSIONDO NOT MODJFY RENAL FUNCTION. ●, V B V L O @ V A L c Cameo a G R R H U & C J a P S M C U M S

P

R

h

e

w

c f r C d t a w t i

A

v

A

t

d

d t

P

t t

f

L

R P R

a

1

D

C

b

t

F

C

M

L w d i e e c ( a e

A

.

E

E

K

sstihyperteneive Drssg 129A A- POSTERS: P 1 AO V R O Treatment f R L L

A

E f

m e a

g a i t t

t

cel r c r ml

w

e w

p T c a s

a r e w

w t

a i t h

w

e c

f w

oA

c

A i

r

r u l

bio o& t

ee l l s it u

es eoo m u er e

y y

e

a m

n e

A m e C d c

r n

y

i